Multivariable analysis of the effects of prognostic factors on (A) 3-year disease-free survival and (B) locoregional recurrence. CEA, carcinoembryonic antigen; FU, fluorouracil; mFOLFOX6, modified infusional fluorouracil, leucovorin, and oxaliplatin; OR, odds ratio; RT, radiotherapy.